SMALLCAPSDAILYNews / Catalysts / OpportunityGet the Daily Brief
Ticker HubNasdaq

INO

Inovio Pharmaceuticals, Inc.

PHARMACEUTICAL PREPARATIONSLatest afterhours mover

Latest price

$2.06+166.91%

As of Oct 30, 2026, 8:00 PM EDT · Market data by Massive

Market cap

$79.8M

Volume

80.5M

Previous close

$0.7718

Day range

$0.5961 – $0.8637

Listed

Dec 8, 1998

Coverage

1 article

Price performance

Recent trading

5 trading days · 15-minute intervals · ET
$2.51$2.03$1.56$1.08$0.6038Mon, 10/26Tue, 10/27Wed, 10/28Thu, 10/29Fri, 10/30
Five-day open $0.9200Latest interval $2.06

Newsroom

Latest INO coverage

NanoViricides: Drug Candidates Show Fantastic Results In Animal Model
BiotechMay 20, 2020

NanoViricides: Drug Candidates Show Fantastic Results In Animal Model

In our earlier pieces, we have provided an in-depth coverage of the promising biopharma smallcap NanoViricides Inc. (NYSE American: NNVC) and its huge potential within the anti-viral medications space. The company has rapidly advancement with respect to the drug development process of its COVID-19 drug and a big role was played by CEO Dr. Anil ...

NNVCSRNEINONVAX

Recent catalyst headlines

INOVIO Announces FDA Accelerated Approval of VOCERYQ™, an Immunotherapy to Reduce the Frequency of Surgery in Adults with Recurrent Respiratory Papillomatosis (RRP)

Oct 30, 2026

Inovio Nears FDA Decision on INO-3107 as Oct. 30 PDUFA Date Looms

Sep 11, 2026

Inovio Pharmaceuticals Nears Oct. 30 FDA Decision for INO-3107 in RRP

Sep 10, 2026

Market data may be delayed and is provided for informational purposes only. SmallCapsDaily content is not investment advice.